Skip to content

On managing innovation, generative AI, and pharma industry

A conversation with Dr. Andree Bates of the AI For Pharma Growth podcast.

Bruno Pešec
Bruno Pešec
1 min read
On managing innovation, generative AI, and pharma industry

I've recently had a great conversation with Dr. Andree Bates of the AI For Pharma Growth, discussing innovation, AI, and pharma industry:

They explore the distinction between doing and managing innovation, emphasising the pitfalls to avoid. Bruno highlights the significance of investing wisely, steering clear of ideas with limited market potential. Overcoming executive fear of innovation and understanding market scale are crucial.

They discuss the importance of creating a budget for innovative ideas, releasing funding incrementally, and combining data with human intuition for decision-making. The role of AI is considered, along with risks tied to innovation implementation and metrics for measuring success. They also examine successful business models in pharma, alongside a practical guide to lean experimentation.

You can listen to the episode here or by using the player below:

PodcastInnovationStrategy

Bruno Pešec

I help business leaders innovate profitably at scale.

Comments


Related Posts

Members Public

The Puzzle Episode 29

What does your favourite product reveal about you?

The Puzzle Episode 29
Members Public

Wednesday Innovation Q&A with Bruno

How do we provide the space, tooling and methodologies for innovation to teams?

Wednesday Innovation Q&A with Bruno
Members Public

Maintenance

Important but insufficient.

Bruno Unfiltered